![]() |
|
|
Vol. 281, Issue 3, 1120-1126, 1997
,Institute of Physiology, Academy of Sciences of the Czech Republic (P.M., A.M.) and Department of Pathophysiology, 3rd Medical School, Charles University (M.P.), Prague, Czech Republic
| |
Abstract |
|---|
|
|
|---|
Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX), a competitive antagonist at non-N-methyl-D-aspartate receptors for excitatory amino acids, was studied in a model of cortical epileptic afterdischarges (ADs) in 12-, 18- and 25-day-old rat pups with implanted electrodes. Electrical stimulation of sensorimotor cortex was repeated four times with 20-min intervals, NBQX (in doses of 10, 30, 60 or 90 mg/kg i.p.) or solvent (dimethyl sulfoxide, 1 ml/kg i.p.) were injected 10 min after the first afterdischarge. Dimethyl sulfoxide did not change the phenomena recorded; NBQX shortened ADs or at least blocked progressive prolongation observed under control conditions. Intensity of movements accompanying stimulation decreased after NBQX, and clonic movements accompanying ADs were suppressed in a dose-dependent manner. The highest dose of NBQX disabled the animals; therefore, the action of this drug on motor skills was studied in another group of animals. Even the dose of 30 mg/kg NBQX interfered with motor performance in 12- and 18-day-old rat pups, 25-day-old rat pups were more resistant to this action. NBQX exhibited only moderate antiepileptic action (suppression of progressive lengthening of ADs) at doses where unwanted side effects were absent.
| |
Introduction |
|---|
|
|
|---|
Most types of epileptic seizures
are caused by a disturbance of equilibrium between excitation and
inhibition in the central nervous system (Heinemann and Jones, 1991
).
Drugs, which restore this equilibrium, may be effective
anticonvulsants. There are two possible ways to restore this
equilibrium: potentiation of inhibition or suppression of excitation
(Mutani et al., 1991
; Heinemann et al., 1994
).
Both possibilities are studied extensively in adult animals (Meldrum,
1989
; Chapman, 1991
). Practically all known antagonists of excitatory
amino acids exhibit anticonvulsant action (for review see Dingledine
et al., 1990
; Chapman, 1991
). For a long time attention was
focused on antagonists of NMDA type of receptors because competitive
(2-amino-5-phosphonovaleric acid, 2-amino-7-phosphonoheptanoic acid and
CPP; Watkins, 1991
) as well as noncompetitive antagonists binding to
the ion channel regulated by NMDA receptor (e.g., ketamine
and dizocilpine, i.e., MK-801; Foster, 1991
) were at
disposal (Watkins et al., 1990
). Unwanted side effects
stopped the clinical trials of dizocilpine in spite of its marked
anticonvulsant action (Troupin et al., 1986
). With the
discovery of specific nonNMDA receptor antagonists, competitive NBQX
(Sheardown et al., 1990
) and noncompetitive GYKI 52466 (Tarnawa et al., 1990
), the attention was shifted to this
class of drugs. Both these antagonists exhibit clear-cut anticonvulsant
effect in various models of epileptic seizures in adult rats (Chapman et al., 1991
; Smith et al., 1991
; Meldrum
et al., 1992
; Löscher et al., 1993
;
Yamaguchi et al., 1993
; Dürmüller et
al., 1994
; Lallement et al., 1994
; Löscher and
Honack, 1994
), but nothing is known about their possible action in
immature brain. There are developmental changes in concentration of
nonNMDA receptors in rat brain (Miller et al., 1990
), which
suggests a possibility of changing sensitivity. Because of this
possibility we started ontogenetic studies in rats. Our first study
demonstrated a moderate action of NBQX against
pentylenetetrazol-induced motor seizures at all developmental stages
(7-, 12-, 18- and 25-day-old rats). This action was rather specific
against the tonic phase of generalized tonic-clonic seizures leaving
minimal, clonic seizures untouched (Velí
ek et
al., 1995). We continued our study of NBQX anticonvulsant action
in another model of epileptic seizures: epileptic ADs elicited by
electrical stimulation of sensorimotor cortex and accompanied by clonic
seizures similar to those induced by pentylenetetrazol (Kubová
et al., 1993
). Recent results with a noncompetitive nonNMDA antagonist GYKI 52466 demonstrated an anticonvulsant action in all age
groups studied (12-, 18- and 25-day-old rats; Kubová, H., Vilagi,
I., Mikulecká, A. and Mare
, P., submitted) and our present study demonstrates similar action of NBQX. Action of NBQX on
motor system was described in mice (facilitation of dopamine D1
receptor agonist-induced locomotion, Starr and Starr, 1993
; suppression
of locomotor stimulant action of methamphetamine, Witkin, 1993
),
therefore unwanted side effects may be expected. To delineate these
possible effects, the influence of NBQX on motor performance of
immature rats was studied in identical age groups as the anticonvulsant
action. This part of our study was based on developmental studies of
Altman and Sudarshan (1975)
, in which a battery of tests with basic
ontogenetic data is described. It was thus possible to choose tests
adequate for our age groups. The tests of motor skills do not stress
rat pups, because they represent a play rather than a task for the
animals.
| |
Methods |
|---|
|
|
|---|
Experiments were performed in Wistar albino rats (Charles River) in three age groups (12, 18 and 25 days old) raised in our laboratory. The environmental temperature was 21-23°C. The colony room was naturally illuminated; food and water were available ad libitum. All experiments were performed between 9 A.M. and 3 P.M.
Electrophysiology
Experiments were performed in 119 rats. Cortical electrodes were
implanted epidurally under ether anesthesia: two stimulation electrodes
were placed over the right sensorimotor area, and recording electrodes
were placed over the left sensorimotor area and visual areas of both
hemispheres. An indifferent electrode was localized in the nasal bone
(for details see Kubová et al., 1993
). Surgical preparation lasted less than 15 min. After interruption of ether anesthesia the animals were allowed to recover for at least 1 hr, after
which they were neurologically examined (righting and placing reflexes)
and fed by sucrose solution. Only then were the experiments started.
Stimulation was performed by means of a constant current stimulator of
our own construction. Stimulation series lasted 15 sec and were formed
by biphasic rectangular pulses of 1-msec duration and 8-Hz frequency.
Intensity of stimulation was always suprathreshold, i.e.,
the first stimulation invariably elicited an AD of the spike-and-wave type (fig. 1). Absolute values of intensity ranged from
2.5 to 5 mA. These stimulation series were repeated four times with
20-min intervals between the end of AD and the beginning of the
subsequent stimulation.
|
The first AD always served as a control. Ten minutes after its end the animals were injected intraperitoneally either with NBQX (freshly dissolved in dimethyl sulfoxide so that the volume of 1 ml/kg was always administered) in one of the following doses: 10, 30, 60 or 90 mg/kg or with dimethyl sulfoxide in a volume of 1 ml/kg. Each age and dose group consisted of seven to nine animals.
Electrocorticogram was recorded before and during stimulation, during
the AD and 1 min after its end. Behavior of animals was marked into EEG
recordings. Type and duration of ADs were evaluated. Racine's
five-point scale (Racine, 1972
), modified only in point 1, was used for
quantification of behavior: 0, no activity; 1, activities asynchronous
with stimuli or sharp elements of ADs; 2, head jerks; 3, clonic
forelimb movements; 4, clonic forelimb movements + rearing; 5, clonic
forelimb movements + rearing + falling. Activities under points 2 to 5 were synchronous with stimuli or sharp elements in the
electrocorticogram during ADs. The most severe behavioral phenomenon
was taken as a score, then the average and standard error of the mean
were calculated for each group. Statistical evaluation of duration of
ADs was done by means of three-dimensional analysis of variance
(factors age, dose and number of stimulation) with post hoc
comparison of individual groups by Holm's method (Holm, 1979
).
Behavioral scores were evaluated with Friedman's and Kruskal-Wallis
nonparametric analysis with multiple comparison tests (Dixon, 1988
).
Five percent level was taken as statistically significant.
Motor Skills
Motor skills were tested in 280 rats in the same three age groups, i.e. 12, 18 and 25 days old. Entire litters (eight pups) were tested. In each litter two rat pups served as naive controls, six rats were injected intraperitoneally either with NBQX or dimethyl sulfoxide. The NBQX solution was prepared similarly as for the electrophysiological experiments. The 30 mg/kg dose of NBQX was administered to all age groups. The second dose of NBQX was chosen according to the results with the 30 mg/kg dose in individual age groups to find the dose which does not interfere with motor performance. Twenty-five-day-old animals received the 60 mg/kg dose, the two younger groups the 10 mg/kg dose. Solvent control group was injected with dimethyl sulfoxide in a volume of 1 ml/kg. The rats were tested between 10 and 40 min after the drug or solvent administration.
The following five tests, slightly modified from the battery described
by Altman and Sudarshan (1975)
, were used.
Surface righting reflex. Pups were placed on a laboratory desk in a supine position, three trials were evaluated each for 60 sec at maximum. Time of righting and consistent placement of hindlimbs along the abdomen was recorded. The test was repeated at the end of the session, i.e,. approximately 40 min after NBQX administration.
Negative geotactic reaction. Pups were placed on an inclined (30°) rough surface with the head facing downward (0°). The ability of pups to turn to 90° and consequently to 180° as well as time to turn were recorded. The animals were tested for maximum time of 90 sec.
Bar holding. Pups were held so that their forepaws touched a 25-cm-long wooden rod with a diameter of 1 cm, hanging 25 cm above a padded surface. Time of grasping the bar was recorded, time limit was 120 sec. In addition, the hindlimb support of the body was also recorded.
Wire-mesh ascending. A surface consisting of 10-mm wire mesh, 45 cm high and 15 cm wide, was placed at an angle of 70° in contact with a platform on the top and with an edge of laboratory desk at the bottom. The wire mesh was divided into five sections. To promote the ascending of a rat pup, its littermates were placed on the top platform while the tested rat was placed at the bottom of the wire mesh. Distance of climbing up for rejoining the siblings was measured up to 120 sec.
Crossing a bridge. The test consisted of two elevated platforms (start and goal) connected by a plywood bridge (30 cm long and 3 cm wide) divided into five sections. A litter of animals was placed on the goal platform, and one pup at a time was removed and placed on the start platform. During the 120-sec observation period distance traversed to join littermates or to fall was measured.
In the tests of bar holding, wire mesh and crossing bridge a box with a soft cover at the base served as a protection for the falling pups. Nonparametric methods were used for statistical analysis. Differences among individual measurements were evaluated with the Kruskal-Wallis One Way Analysis of Variance on Ranks test. The level of statistical significance was set again at 5%.| |
Results |
|---|
|
|
|---|
Electrophysiology. The first predrug stimulation always induced an EEG AD formed by spike-and-wave rhythm in 25- and 18-day-old rats or rhythmic sharp waves in 12-day-old rat pups. Stimulation elicited clonic movements of head and forelimbs synchronous with individual stimuli; the ADs were accompanied by similar movements (clonic seizures) synchronous with sharp elements in the EEG. The first AD was longest in 12-day-old rat pups (10.9 sec on the average) and its duration decreased with age to 9.3 and 7.2 sec in 18- and 25-day-old rats, respectively. The differences between individual age groups were significant.
Progressive prolongation of ADs with repeated stimulations was present in 12-day-old rat pups. Rats 25 days old exhibited the prolongation of the second AD, but the duration of the third and fourth ADs tended to be shorter than the second AD. The changes in 18-day-old animals did not reach the level of statistical significance. Intensity of movements accompanying stimulation as well as of clonic seizures remained stable during repeated stimulations. Dimethyl sulfoxide did not change any parameter of ADs or motor phenomena in any age group when compared with naive age-matched controls. NBQX did not change the pattern of ADs, but shortened the duration of ADs in a dose-dependent manner in all age groups (fig. 2). In 12-day-old rat pups the two lower doses suppressed, at least temporarily, the increase in duration of ADs with repeated stimulations. The 60-mg/kg dose resulted in a complete block of ADs in four out of eight animals, and ADs could be recorded only exceptionally after the 90-mg/kg dose. In 18-day-old rats the 10-mg/kg dose did not have significant effect, the 30- and 60-mg/kg doses shortened ADs temporarily and the highest dose was necessary for reliable suppression of ADs. Similar results were found in 25-day-old rats with the only exception that the increase in duration was reliably blocked by all doses of NBQX (the postdrug ADs were significantly shorter than the corresponding ADs in the control, dimethyl sulfoxide group).
|
|
|
Motor skills. In all five tests, there were no differences between the control noninjected and dimethyl sulfoxide-treated groups, but there were differences in the bar-holding test in 12-day-old rat pups, where solvent shortened the time of grasping the bar.
In the righting ability test performed at the beginning of testing (fig. 5), the dose of 10 mg/kg NBQX did not significantly lengthen the latency of turning from a supinal to normal position. The dose of 30 mg/kg significantly increased the latency of turnings in 12- and 18-day-old but not in 25-day-old rats. The dose of 60 mg/kg also led to the increased latency of turning in 25-day-old rats. The differences between control and NBQX-treated rats failed to reach statistical significance when the test was repeated 40 min after NBQX administration.
|
|
| |
Discussion |
|---|
|
|
|---|
Three different phenomena could be evaluated in our electrophysiological experiments: movements accompanying stimulation (i.e., the direct activation of the motor system), generation and progressive augmentation of ADs and motor seizures accompanying ADs (i.e., the spread of epileptic activity into the motor system).
In agreement with results of Jensen et al. (1995)
obtained
in hypoxia-induced epileptogenesis in 10-day-old rat pups, NBQX exhibited a marked anticonvulsant action in immature rats in our model.
This action was expressed in shortening of the duration of ADs up to
the abolition of ADs after the highest dose, as well as in a decrease
of intensity of clonic seizures accompanying cortical ADs. Dimethyl
sulfoxide, used as a solvent for NBQX, did not possess these actions.
Three different anticonvulsant actions could be hypothesized based on
changes found: 1) the action against progressive epileptogenesis as the
most marked effect is suggested by a block of progressive increase of
duration of ADs with low doses of NBQX; 2) the action against
generation of epileptic ADs is demonstrated by complete suppression of
ADs by higher doses of NBQX; 3) the action against spread of epileptic activity at least into the motor system is demonstrated by the appearance of ADs without any motor correlate after high doses of NBQX.
Our data on AD duration differ from those of Dürmüller et al. (1994)
, which describe the reduction of seizure score
but not shortening of ADs in fully kindled rats (amygdala kindling) and
no significant effect on kindling development. The suppression of ADs
in our experiment is caused by the higher doses used. The difference in
the effect on progressive prolongation of ADs, which was found even
with very low dose (10 mg/kg), might be caused by two factors: cortical
ADs are more sensitive to NBQX action than amygdala ADs, and immature
rats exhibit higher sensitivity to NBQX than adult animals. Both
explanations are plausible. In addition, a possible difference between
classical kindling in the paper of Dürmüller et
al. (1994)
and partial, initial kindling (Racine et
al., 1973
) in our study has to be taken into account. This
possible difference is suggested by figure 6 in
Dürmüller's study which demonstrated transient suppression
of kindling development on the first day of NBQX administration,
i.e., under the conditions similar to our paradigm of
partial kindling when stimulations were repeated with much shorter
intervals after a single injection of NBQX.
Effects of NBQX on the motor system were demonstrated not only as a
modification of movements elicited by stimulation of the sensorimotor
cortical area by high doses but also as worsening of performance in
motor skill tests where even low doses led to significant results.
Action on the motor system had to be expected because of physiological
role of excitatory amino acids in this system. At least the
corticostriate pathway (i.e., the first neuron in the
extrapyramidal system), as well as the corticorubral pathway, uses
glutamate as its transmitter (Headley and Grillner, 1990
). In addition,
the effects of NBQX on spinal cord ventral root reflexes were
demonstrated (Farkas and Ono, 1995
).
The effects of NBQX on the motor system are markedly expressed so that
only the first of the three anticonvulsant actions enumerated above is
exhibited by doses not derranging motor performance of rat pups. The
other anticonvulsant effects were observed only after doses inducing
marked side effects. These results demonstrate a narrow therapeutic
range of NBQX in immature rats. In addition, the difference between
anticonvulsant and toxic effects is related to the age of animals; it
increases with maturation, i.e., the therapeutic index
increases during development. Our results from 25-day-old rats are in
agreement with data from adult mice in which anticonvulsant effects
were always more marked than motor-impairing effects (Swedberg et
al., 1995
).
Higher sensitivity of younger animals in comparison with older ones,
which was seen in both electrophysiological and motor skills
experiments, might be caused by the larger amount of AMPA receptors in
most brain regions at the end of the third postnatal week in comparison
with older animals (Insel et al., 1990
), but the published
data demonstrate the same concentration of AMPA receptors in 14- and
28-day-old rats with the only exception of CA3 hippocampal field where
the 14-day-old pups have more AMPA receptors than older rats (Insel
et al., 1990
). On the other hand, Blue and Johnston (1995)
found the peak of quisqualate receptors in the rat somatosensory cortex
at postnatal day 10, but they did not differentiate between
metabotropic and AMPA receptors with the exception of localization in
relation to barrels in layer IV on postnatal day 10 only. Regional
differences were found during development also in an in situ
hybridization of GluR-1, GluR-2, GluR-3 and GluR-4 genes
(PellegriniGiampietro et al., 1991; Bettler et
al., 1990
). Developmental changes in the composition of subunit proteins of the AMPA-preferring glutamate receptor which were demonstrated in individual thalamic nuclei (Spreafico et
al., 1994
) and in the whole telencephalon (Hall and Bahr, 1994
)
might also form a background for high sensitivity of rat pups.
Unfortunately, there are no available data on the binding of NBQX to
different subunits during brain maturation. In addition, data of Insel
et al., (1990)
that KD remains the
same in 21-day-old and adult rats speak against this explanation, but
these authors did not publish KD data for
younger animals.
Our recent data demonstrated anticonvulsant action of NBQX against the
tonic phase of generalized tonic-clonic seizures elicited by
pentylenetetrazol in rat pups (Velí
ek et al.,
1995), which indicates possible clinical effects against generalized
tonic seizures. Cortical epileptic ADs used in the present paper may be
taken as a model of myoclonic seizures (Kubová et al.,
1996
; Polá
ek et al., 1996
); therefore, the
action of NBQX in this model might predict efficacy against human
myoclonic seizures. Marked anticonvulsant action of NBQX is accompanied
by an impairment of motor functions as demonstrated with doses
effective in maximal electroshock model in adult mice (Yamaguchi
et al., 1993
). Developmental changes of these unwanted
effects shown in our present study indicate higher sensitivity of the
immature brain. This fact might impede clinical use of NBQX and
probably also other nonNMDA antagonists at least in pediatric
epileptology.
| |
Footnotes |
|---|
Accepted for publication February 24, 1997.
Received for publication August 5, 1996.
1 This study was supported by a grant of the Grant Agency of the Czech Republic No. 309/93/0579 and by a grant of Charles University No. 227.
Send reprint requests to: P. Mare
, M.D., D.Sc.,
Institute of Physiology, Academy of Sciences of the Czech Republic,
Víde
ská 1083, CZ 142 20 Prague 4, Czech Republic.
| |
Abbreviations |
|---|
Ads, afterdischarges;
AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazole propionate;
NBQX, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline;
NMDA, N-methyl-d-aspartate;
EEG, electroencephalogram.
| |
References |
|---|
|
|
|---|
S21, 1994.
, P. and
Vorlí
ek, J.:
Stable anticonvulsant action of benzodiazepines during development in rats.
J. Pharm. Pharmacol.
45: 807-810, 1993[Medline].
tiaková, M.,
Mocková, M.,
Mare
, P. and
Vorlí
ek, J.:
Pharmacology of cortical epileptic afterdischarges in rats.
Epilepsia
37: 336-341, 1996[Medline].
ek, R.,
Kubová, H.,
lamberová, R.,
Mare
, P. and
Vorlí
ek, J.:
Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibition.
Epilepsy Res.
25: 177-184, 1996[Medline].
ek, L.,
Kubová, H.,
Mare
, P. and
Vachová, D.:
Kainate/AMPA receptor antagonists are anticonvulsant against the tonic hindlimb component of pentylenetetrazol-induced seizures in developing rats.
Pharmacol. Biochem. Behav.
51: 153-158, 1995[Medline].
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||